New Hampshire Trust’s Labcorp LH Stock Holding History

New Hampshire Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-761	Closed	-$150K	–	259
2023 Q1	$150K	Hold	761	–	–	0.04%	185
2022 Q4	$154K	Buy	+761	New	+$149K	0.04%	186

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New Hampshire Trust's LH Position: Q2 2023 in Review

New Hampshire Trust sold out of Labcorp (LH) in Q2 2023, closing a stake of 761 shares — an estimated $150K sold.

New Hampshire Trust first reported a position in LH in Q4 2022 and held it in 2 quarters. The position peaked at $154K in Q4 2022. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

New Hampshire Trust reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
New Hampshire Trust sold 761 Labcorp shares in Q2 2023, an estimated $150K.
New Hampshire Trust first reported a position in Labcorp in Q4 2022 and held it in 2 quarters.
New Hampshire Trust's Labcorp position peaked at $154K in Q4 2022.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.